HSA 公布 Famodine 20mg 片（批号 232218）2 类零售级召回
Recall of Famodine Tablet 20mg (Famotidine)
HSA 公布 Famodine Tablet 20mg（批号 232218）的 2 类零售级召回，原因为检验结果不符合规定。该产品活性成分为 Famotidine，注册号 SIN09129P，当地公司为 Duopharma (Singapore) Pte Ltd，召回日期为 2026 年 3 月 24 日。HSA 要求医院、诊所和药房停止供应受影响批次，并将剩余库存退回公司。
HSA 把本次 Famodine 片召回列为 2 类零售级，并说明召回不必然代表产品不安全，可用于对照召回分级与处置口径。
Recall details
Date of recall: | 24 March 2026 |
Product: | Famodine Tablet 20mg |
Active Ingredient: | Famotidine |
Product Category: | Therapeutic product |
Registration Number: | SIN09129P |
Batch No.: | 232218 |
Class of Recall: | 2 |
Level of Recall: | Retail |
Local Company: | Duopharma (Singapore) Pte Ltd |
Description of Issue: | Out-of-specification results |
Recall Instructions: | Hospitals, clinics, pharmacies Stop supplying the affected batch and return the remaining stocks to the company. |
Note:
The Health Sciences Authority (HSA) publishes information regarding recalls of health products supplied in Singapore. These product recalls may be conducted on a company’s own initiative or upon HSA’s request to remove products where there are issues with quality, safety or efficacy.
When a recall is initiated, it does not necessarily imply that a product is considered unsafe or is inefficacious. A recall can also be initiated to remove products with quality defects that does not impact safety or efficacy from the market so as to ensure that products registered in Singapore continue to meet the stringent regulatory standards stipulated by HSA.
Not all recalls will lead to press releases. However, when a recall involves a product that has been widely distributed or a product that poses a serious health risk, HSA will issue a press release to inform members of public.
Class of recall
A recall is classified as Class 1 or Class 2 depending on the potential hazard of the issue.
Class 1: For recalls of products with issues that can potentially cause serious adverse health outcomes or death.
Class 2: For recalls of products with issues that would not likely cause serious adverse health outcomes.
Level of recall
The level of product recall will depend on the potential hazard of the affected product, extent of distribution and whether other mitigating measures can be taken to address the issue.
Consumer level: Affected product or batch(es) recalled from patients and consumers as well as wholesale suppliers, retail suppliers, hospitals, clinics and pharmacies.
Retail level: Affected product or batch(es) recalled from retail suppliers, hospitals, clinics and pharmacies as well as wholesale suppliers.
Wholesale level: Affected product or batch(es) recalled from wholesale suppliers.
来源：HSA 治疗药品召回 · hsa.gov.sg